PepGen Inc. (PEPG)
PEPG Stock Price Chart
Explore PepGen Inc. interactive price chart. Choose custom timeframes to analyze PEPG price movements and trends.
PEPG Company Profile
Discover essential business fundamentals and corporate details for PepGen Inc. (PEPG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
6 May 2022
Employees
79.00
Website
https://www.pepgen.comCEO
James G. McArthur
Description
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
PEPG Financial Timeline
Browse a chronological timeline of PepGen Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 23 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.72.
Earnings released on 7 Aug 2025
EPS came in at -$0.70 surpassing the estimated -$0.85 by +17.65%.
Earnings released on 8 May 2025
EPS came in at -$0.92 falling short of the estimated -$0.72 by -27.78%.
Earnings released on 24 Feb 2025
EPS came in at -$0.68 surpassing the estimated -$0.81 by +16.05%.
Earnings released on 7 Nov 2024
EPS came in at -$0.66 surpassing the estimated -$0.87 by +24.14%.
Earnings released on 8 Aug 2024
EPS came in at -$0.87 falling short of the estimated -$0.72 by -20.83%.
Earnings released on 14 May 2024
EPS came in at -$0.63 surpassing the estimated -$0.74 by +14.86%.
Earnings released on 6 Mar 2024
EPS came in at -$0.82 surpassing the estimated -$1.01 by +18.81%, while revenue for the quarter reached $1.66M .
Earnings released on 8 Nov 2023
EPS came in at -$0.98 falling short of the estimated -$0.88 by -11.36%.
Earnings released on 8 Aug 2023
EPS came in at -$0.82 falling short of the estimated -$0.81 by -1.23%.
Earnings released on 11 May 2023
EPS came in at -$0.69 surpassing the estimated -$0.79 by +12.66%.
Earnings released on 23 Mar 2023
EPS came in at -$0.96 falling short of the estimated -$0.87 by -10.34%.
Earnings released on 10 Nov 2022
EPS came in at -$0.79 surpassing the estimated -$1.00 by +21.00%.
Earnings released on 12 Aug 2022
EPS came in at -$1.23 falling short of the estimated -$0.76 by -61.84%.
Earnings released on 9 May 2022
EPS came in at -$0.89 surpassing the estimated -$0.89 by +0.31%.
Earnings released on 31 Dec 2021
EPS came in at -$7.75 .
Earnings released on 30 Sept 2021
EPS came in at -$1.05 .
Earnings released on 30 Jun 2021
EPS came in at -$0.70 .
Earnings released on 31 Mar 2021
EPS came in at -$0.86 .
Earnings released on 31 Dec 2020
EPS came in at -$0.04 .
Earnings released on 30 Sept 2020
EPS came in at -$0.02 .
PEPG Stock Performance
Access detailed PEPG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.